Copyright Reports & Markets. All rights reserved.

Global CRISPR-Based Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Genome Editing
    • 1.4.3 Genetic Engineering
    • 1.4.4 gRNA Database/Gene Librar
    • 1.4.5 CRISPR Plasmid
    • 1.4.6 Human Stem Cells
    • 1.4.7 Genetically Modified Organisms/Crops
    • 1.4.8 Cell Line Engineering
  • 1.5 Market by Application
    • 1.5.1 Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Biotechnology Companies
    • 1.5.3 Pharmaceutical Companies
    • 1.5.4 Academic Institutes
    • 1.5.5 Research and Development Institutes
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 CRISPR-Based Therapeutics Market Perspective (2015-2026)
  • 2.2 CRISPR-Based Therapeutics Growth Trends by Regions
    • 2.2.1 CRISPR-Based Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 CRISPR-Based Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 CRISPR-Based Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key CRISPR-Based Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top CRISPR-Based Therapeutics Players by Market Size
    • 3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global CRISPR-Based Therapeutics Market Concentration Ratio
    • 3.2.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2019
  • 3.3 CRISPR-Based Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players CRISPR-Based Therapeutics Product Solution and Service
  • 3.5 Date of Enter into CRISPR-Based Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2021-2026)

5 CRISPR-Based Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global CRISPR-Based Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America CRISPR-Based Therapeutics Market Size (2015-2020)
  • 6.2 CRISPR-Based Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America CRISPR-Based Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe CRISPR-Based Therapeutics Market Size (2015-2020)
  • 7.2 CRISPR-Based Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe CRISPR-Based Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China CRISPR-Based Therapeutics Market Size (2015-2020)
  • 8.2 CRISPR-Based Therapeutics Key Players in China (2019-2020)
  • 8.3 China CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 8.4 China CRISPR-Based Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan CRISPR-Based Therapeutics Market Size (2015-2020)
  • 9.2 CRISPR-Based Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan CRISPR-Based Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia CRISPR-Based Therapeutics Market Size (2015-2020)
  • 10.2 CRISPR-Based Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia CRISPR-Based Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India CRISPR-Based Therapeutics Market Size (2015-2020)
  • 11.2 CRISPR-Based Therapeutics Key Players in India (2019-2020)
  • 11.3 India CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 11.4 India CRISPR-Based Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America CRISPR-Based Therapeutics Market Size (2015-2020)
  • 12.2 CRISPR-Based Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America CRISPR-Based Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America CRISPR-Based Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Caribou Biosciences
    • 13.1.1 Caribou Biosciences Company Details
    • 13.1.2 Caribou Biosciences Business Overview and Its Total Revenue
    • 13.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction
    • 13.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2015-2020))
    • 13.1.5 Caribou Biosciences Recent Development
  • 13.2 Addgene
    • 13.2.1 Addgene Company Details
    • 13.2.2 Addgene Business Overview and Its Total Revenue
    • 13.2.3 Addgene CRISPR-Based Therapeutics Introduction
    • 13.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.2.5 Addgene Recent Development
  • 13.3 CRISPR THERAPEUTICS
    • 13.3.1 CRISPR THERAPEUTICS Company Details
    • 13.3.2 CRISPR THERAPEUTICS Business Overview and Its Total Revenue
    • 13.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction
    • 13.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.3.5 CRISPR THERAPEUTICS Recent Development
  • 13.4 Merck KGaA
    • 13.4.1 Merck KGaA Company Details
    • 13.4.2 Merck KGaA Business Overview and Its Total Revenue
    • 13.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction
    • 13.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.4.5 Merck KGaA Recent Development
  • 13.5 Mirus Bio LLC
    • 13.5.1 Mirus Bio LLC Company Details
    • 13.5.2 Mirus Bio LLC Business Overview and Its Total Revenue
    • 13.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction
    • 13.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.5.5 Mirus Bio LLC Recent Development
  • 13.6 Editas Medicine
    • 13.6.1 Editas Medicine Company Details
    • 13.6.2 Editas Medicine Business Overview and Its Total Revenue
    • 13.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction
    • 13.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.6.5 Editas Medicine Recent Development
  • 13.7 Takara Bio USA
    • 13.7.1 Takara Bio USA Company Details
    • 13.7.2 Takara Bio USA Business Overview and Its Total Revenue
    • 13.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction
    • 13.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.7.5 Takara Bio USA Recent Development
  • 13.8 Thermo Fisher Scientific
    • 13.8.1 Thermo Fisher Scientific Company Details
    • 13.8.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction
    • 13.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.8.5 Thermo Fisher Scientific Recent Development
  • 13.9 Horizon Discovery Group
    • 13.9.1 Horizon Discovery Group Company Details
    • 13.9.2 Horizon Discovery Group Business Overview and Its Total Revenue
    • 13.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction
    • 13.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.9.5 Horizon Discovery Group Recent Development
  • 13.10 Intellia Therapeutics
    • 13.10.1 Intellia Therapeutics Company Details
    • 13.10.2 Intellia Therapeutics Business Overview and Its Total Revenue
    • 13.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction
    • 13.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 13.10.5 Intellia Therapeutics Recent Development
  • 13.11 GE Healthcare Dharmacon
    • 10.11.1 GE Healthcare Dharmacon Company Details
    • 10.11.2 GE Healthcare Dharmacon Business Overview and Its Total Revenue
    • 10.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction
    • 10.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2015-2020)
    • 10.11.5 GE Healthcare Dharmacon Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global CRISPR-Based Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR-Based Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Caribou Biosciences
    Addgene
    CRISPR THERAPEUTICS
    Merck KGaA
    Mirus Bio LLC
    Editas Medicine
    Takara Bio USA
    Thermo Fisher Scientific
    Horizon Discovery Group
    Intellia Therapeutics
    GE Healthcare Dharmacon

    Market segment by Type, the product can be split into
    Genome Editing
    Genetic Engineering
    gRNA Database/Gene Librar
    CRISPR Plasmid
    Human Stem Cells
    Genetically Modified Organisms/Crops
    Cell Line Engineering
    Market segment by Application, split into
    Biotechnology Companies
    Pharmaceutical Companies
    Academic Institutes
    Research and Development Institutes

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global CRISPR-Based Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the CRISPR-Based Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of CRISPR-Based Therapeutics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now